The weekly litigation news digest is live. Subscribe now
A Myostatin Pathway Inhibitor In Combination With A Glp-1 Pathway Activator For Use In Treating Metabolic Disorders - EP4358995
The patent EP4358995 was granted to Scholar Rock on Dec 3, 2025. The application was filed on Jun 22, 2022 under application number EP22744054A. The patent is currently recorded with a legal status of "Granted And Under Opposition".
EP4358995
- Application Number
- EP22744054A
- Filing Date
- Jun 22, 2022
- Status
- Granted And Under Opposition
- Oct 31, 2025
- Publication Date
- Dec 3, 2025
- External Links
- Slate, Register, Google Patents
Patent Summary
Patent Family
Patent Oppositions
Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
Patent Citations (44) New
Patent citations refer to prior patents cited during different phases such as opposition or international search.
Dossier Documents
The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Date
Description
Get instant alerts for new documents